1. Clinical outcomes of patients with newly diagnosed atrial fibrillation who refused anticoagulation: findings from the global GARFIELD-AF registry. (25th November 2020) Authors: Apenteng, P; Fitzmaurice, D.A; Virdone, S; Camm, A.J; Fox, K.A.A; Bassand, J.-P; Goldhaber, S.Z; Goto, S; Haas, S; Turpie, A.G.G; Verheugt, F.W.A; Misselwitz, F; Kayani, G; Pieper, K.S; Kakkar, A.K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative effectiveness of NOAC vs VKA in patients representing common clinical challenges: results from the GARFIELD-AF registry. (14th October 2021) Authors: Virdone, S; Himmelreich, J.C.L; Pieper, K.S; Camm, A.J; Bassand, J.-P; Fox, K.A.A; Fitzmaurice, D.A; Goldhaber, S.Z; Goto, S; Haas, S; Kayani, G; Misselwitz, F; Turpie, A.G.G; Verheugt, F.W.A; Kakkar, A.K Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparing rivaroxaban and apixaban in GARFIELD-AF according to ROCKET AF and ARISTOTLE trial selection criteria. (14th October 2021) Authors: Himmelreich, J.C.L; Virdone, S; Camm, A.J; Harskamp, R.E; Pieper, K.S; Fox, K.A.A; Bassand, J.-P; Fitzmaurice, D.A; Goldhaber, S.Z; Goto, S; Haas, S; Misselwitz, F; Turpie, A.G.G; Verheugt, F.W.A; Kakkar, A.K Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF. (25th November 2020) Authors: Camm, A.J; Steffel, J; Virdone, S; Bassand, J.-P; Fitzmaurice, D.A; Fox, K.A.A; Goldhaber, S.Z; Goto, S; Haas, S; Turpie, A.G.G; Verheugt, F.W.A; Misselwitz, F; Kayani, G; Pieper, K.S; Kakkar, A.K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of NOAC and VKA on outcome of patients with newly diagnosed atrial fibrillation and diabetes: a report from the GARFIELD-AF registry. (14th October 2021) Authors: Bassand, J; Virdone, S; Verheugt, F.W.A; Camm, A.J; Cools, F; Fox, K.A.A; Goldhaber, S.Z; Goto, S; Haas, S; Hacke, W; Kayani, G; Misselwitz, F; Pieper, K.S; Turpie, A.G.G; Kakkar, A.K Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Permanent discontinuation of different anticoagulants in patients with atrial fibrillation and the impact on clinical outcome: data from the GARFIELD-AF registry. (25th November 2020) Authors: Cools, F; Johnson, D; Pieper, K.S; Camm, A.J; Bassand, J.-P; Fitzmaurice, D.A; Fox, K.A.A; Goldhaber, S.Z; Goto, S; Haas, S; Turpie, A.G.G; Verheugt, F.W.A; Misselwitz, F; Kayani, G; Kakkar, A.K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rivaroxaban dosing in patients with atrial fibrillation: results from the RIVER registry – is dosing according to renal function appropriate?. (14th October 2021) Authors: Camm, A.J; Virdone, S; Fox, K.A.A; Pieper, K.S; Beyer-Westendorf, J; Le Heuzey, J.-Y; Haas, S; Kayani, G; Gersh, B.J; Turpie, A.G.G; Kakkar, A.K Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and efficacy of apixaban and rivaroxaban versus warfarin in real-world atrial fibrillation patients are similar to their randomized trials: insights from GARFIELD-AF registry. (14th October 2021) Authors: Himmelreich, J.C.L; Virdone, S; Camm, A.J; Harskamp, R.E; Pieper, K.S; Fox, K.A.A; Bassand, J.-P; Fitzmaurice, D.A; Goldhaber, S.Z; Goto, S; Haas, S; Misselwitz, F; Turpie, A.G.G; Verheugt, F.W.A; Kakkar, A.K Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The effect of body mass index on clinical outcomes in patients with newly diagnosed atrial fibrillation in the GARFIELD-AF registry. (25th November 2020) Authors: Camm, C.J.F; Camm, A.J; Virdone, S; Bassand, J.-P; Fitzmaurice, D.A; Fox, K.A.A; Goldhaber, S.Z; Goto, S; Haas, S; Turpie, A.G.G; Verheugt, F.W.A; Misselwitz, F; Kayani, G; Pieper, K.S; Kakkar, A.K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Two-year outcomes of patients with atrial fibrillation treated with rivaroxaban: results from RIVER registry. (14th October 2021) Authors: Beyer-Westendorf, J; Camm, A.J; Virdone, S; Fox, K.A.A; Pieper, K.S; Le Heuzey, J.-Y; Haas, S; Kayani, G; Gersh, B.J; Turpie, A.G.G; Kakkar, A.K Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗